Genflow Biosciences plc (LON:GENF)

London · Delayed Price · Currency is GBP · Price in GBX

1.850

+0.050 (2.75%)

Oct 15, 2026, 4:01 PM GMT

Genflow Biosciences Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.63	0.11	0.28	0.68	2.36	0.22
Cash & Short-Term Investments	0.63	0.11	0.28	0.68	2.36	0.22
Cash Growth	126.36%	-59.88%	-59.26%	-70.97%	951.87%	-11.89%
Other Receivables	0.08	0.3	0.04	0.34	0.13	0.02
Receivables	0.08	0.3	0.04	0.34	0.13	0.02
Prepaid Expenses	0.03	0.04	0.07	0.04	0.13	0.03
Total Current Assets	0.75	0.45	0.38	1.07	2.62	0.28
Property, Plant & Equipment	0	0	0	0	0	-
Total Assets	0.75	0.45	0.39	1.07	2.62	0.28

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.35	0.65	0.37	0.48	0.08	0.04
Accrued Expenses	0.08	0.32	0.07	0.06	0.16	0.17
Current Unearned Revenue	-	0.02	0.33	-	-	-
Other Current Liabilities	0.13	0.02	0.02	0.03	0.01	0.01
Total Current Liabilities	0.56	1	0.79	0.57	0.25	0.22
Total Liabilities	0.56	1	0.79	0.57	0.25	0.22

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.17	0.15	0.1	0.09	0.09	0.07
Additional Paid-In Capital	7.22	6.1	4.83	4.19	4.19	0.63
Retained Earnings	-7.43	-7.01	-5.59	-4	-2.14	-0.81
Comprehensive Income & Other	0.23	0.21	0.25	0.22	0.23	0.16
Shareholders' Equity	0.19	-0.55	-0.4	0.5	2.37	0.06
Total Liabilities & Equity	0.75	0.45	0.39	1.07	2.62	0.28

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash (Debt)	0.63	0.11	0.28	0.68	2.36	0.22
Net Cash Growth	126.36%	-59.88%	-59.26%	-70.97%	951.87%	-11.89%
Net Cash Per Share	0.00	0.00	0.00	0.00	0.01	0.00
Filing Date Shares Outstanding	566.41	493.55	349.71	292.51	292.51	292.51
Total Common Shares Outstanding	566.41	493.55	349.71	292.51	292.51	244.57
Working Capital	0.19	-0.55	-0.41	0.5	2.36	0.06
Book Value Per Share	0.00	-0.00	-0.00	0.00	0.01	0.00
Tangible Book Value	0.19	-0.55	-0.4	0.5	2.37	0.06
Tangible Book Value Per Share	0.00	-0.00	-0.00	0.00	0.01	0.00